EGFR Family Inhibition Identifies P38 MAPK as a Potential Therapeutic Target in Bladder Cancer
Urology - United States
doi 10.1016/j.urology.2017.10.041
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2018
Authors
Publisher
Elsevier BV